Login | New Member? Signup Free
ChangeDetect » News

Tekmira Says USPTO Declares Interference for Alnylam Patent as Firms Continue Litigation

Tekmira Pharmaceuticals this week announced that the US Patent and Trademark Office has declared a patent interference for Alnylam Pharmaceuticals’ US patent covering siRNAs against a key target for its phase I liver cancer drug ALN-VSP.

Tags: , , , , , , , , , , , ,

USPTO Board Rules on PacBio, Life Tech Patent Interference Case

The US Patent and Trademark Office has ruled in a patent interference case involving Pacific Biosciences and Life Technologies, deeming all of Life Tech’s involved claims and the broadest claims of both companies unpatentable, effectively ending the case unless Life Tech decides to appeal. (5 hours ago)

Tags: , , , , , , , , ,

USPTO Board Rules for PacBio in Patent Interference Case with Life Technologies

NEW YORK Pacific Biosciences late Monday announced that a board of the US Patents and Trademark Office has ruled against Life Technologies in a patent interference claim in which PacBio was named the senior party. (2 hours ago)

Tags: , , , , ,